News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
359,499 Results
Type
Article (22325)
Company Profile (308)
Press Release (336866)
Multimedia
Podcasts (61)
Webinars (11)
Section
Business (107753)
Career Advice (1470)
Deals (17419)
Drug Delivery (60)
Drug Development (58675)
Employer Resources (103)
FDA (8043)
Job Trends (7792)
News (189184)
Policy (14569)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (13)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (7)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1463)
Accelerated approval (4)
Adcomms (14)
Allergies (67)
Alliances (26765)
ALS (77)
Alzheimer's disease (1028)
Antibody-drug conjugate (ADC) (113)
Approvals (8058)
Artificial intelligence (200)
Autoimmune disease (21)
Automation (14)
Bankruptcy (139)
Best Places to Work (6691)
BIOSECURE Act (15)
Biosimilars (65)
Biotechnology (248)
Bladder cancer (62)
Brain cancer (21)
Breast cancer (222)
Cancer (1843)
Cardiovascular disease (143)
Career advice (1230)
Career pathing (28)
CAR-T (127)
Cell therapy (373)
Cervical cancer (14)
Clinical research (47983)
Collaboration (693)
Compensation (387)
Complete response letters (15)
COVID-19 (1536)
CRISPR (42)
C-suite (197)
Cystic fibrosis (91)
Data (1781)
Decentralized trials (1)
Denatured (13)
Depression (38)
Diabetes (190)
Diagnostics (2675)
Digital health (10)
Diversity (3)
Diversity, equity & inclusion (25)
Drug discovery (104)
Drug pricing (61)
Drug shortages (15)
Duchenne muscular dystrophy (93)
Earnings (43526)
Editorial (32)
Employer branding (12)
Employer resources (92)
Events (60054)
Executive appointments (590)
FDA (8966)
Featured Employer (46)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (664)
Gene editing (103)
Generative AI (18)
Gene therapy (274)
GLP-1 (515)
Government (2044)
Grass and pollen (6)
Guidances (34)
Healthcare (9789)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (107)
Indications (23)
Infectious disease (1641)
Inflammatory bowel disease (126)
Inflation Reduction Act (9)
Influenza (34)
Intellectual property (75)
Interviews (256)
IPO (9552)
IRA (24)
Job creations (1528)
Job search strategy (1035)
Kidney cancer (8)
Labor market (23)
Layoffs (305)
Leadership (16)
Legal (2278)
Liver cancer (47)
Lung cancer (260)
Lymphoma (122)
Machine learning (5)
Management (34)
Manufacturing (211)
MASH (63)
Medical device (5389)
Medtech (5390)
Mergers & acquisitions (8344)
Metabolic disorders (520)
Multiple sclerosis (66)
NASH (14)
Neurodegenerative disease (78)
Neuropsychiatric disorders (26)
Neuroscience (1497)
NextGen: Class of 2025 (3376)
Non-profit (1994)
Northern California (2110)
Now hiring (25)
Obesity (268)
Opinion (186)
Ovarian cancer (66)
Pain (53)
Pancreatic cancer (71)
Parkinson's disease (132)
Partnered (15)
Patents (158)
Patient recruitment (85)
Peanut (42)
People (32880)
Pharmaceutical (53)
Pharmacy benefit managers (12)
Phase I (16131)
Phase II (21680)
Phase III (15043)
Pipeline (972)
Policy (101)
Postmarket research (1315)
Preclinical (6624)
Press Release (38)
Prostate cancer (88)
Psychedelics (36)
Radiopharmaceuticals (230)
Rare diseases (340)
Real estate (2521)
Recruiting (44)
Regulatory (11656)
Reports (20)
Research institute (1380)
Resumes & cover letters (245)
Rett syndrome (4)
RNA editing (4)
RSV (25)
Schizophrenia (65)
Series A (121)
Series B (77)
Service/supplier (5)
Sickle cell disease (50)
Southern California (1820)
Special edition (14)
Spinal muscular atrophy (123)
Sponsored (23)
Startups (2814)
State (1)
Stomach cancer (6)
Supply chain (46)
Tariffs (18)
The Weekly (47)
United States (17073)
Vaccines (413)
Venture capitalists (39)
Weight loss (169)
Women's health (22)
Worklife (14)
Date
Today (38)
Last 7 days (521)
Last 30 days (1936)
Last 365 days (25391)
2025 (8070)
2024 (25777)
2023 (27356)
2022 (33175)
2021 (34708)
2020 (31173)
2019 (24308)
2018 (17840)
2017 (18600)
2016 (16784)
2015 (19659)
2014 (14312)
2013 (10586)
2012 (10926)
2011 (11116)
2010 (10141)
Location
Africa (403)
Alabama (47)
Alaska (3)
Arizona (89)
Arkansas (9)
Asia (24155)
Australia (3925)
California (4858)
Canada (1373)
China (417)
Colorado (194)
Connecticut (224)
Delaware (128)
Europe (52303)
Florida (610)
Georgia (147)
Idaho (27)
Illinois (359)
India (16)
Indiana (173)
Iowa (10)
Japan (125)
Kansas (72)
Kentucky (11)
Louisiana (9)
Maine (49)
Maryland (620)
Massachusetts (3680)
Michigan (113)
Minnesota (232)
Mississippi (1)
Missouri (55)
Montana (15)
Nebraska (9)
Nevada (24)
New Hampshire (27)
New Jersey (1283)
New Mexico (16)
New York (1321)
North Carolina (668)
North Dakota (5)
Northern California (2110)
Ohio (142)
Oklahoma (10)
Oregon (28)
Pennsylvania (948)
Puerto Rico (7)
Rhode Island (21)
South America (505)
South Carolina (7)
South Dakota (1)
Southern California (1820)
Tennessee (58)
Texas (622)
Utah (76)
Virginia (125)
Washington D.C. (50)
Washington State (415)
West Virginia (3)
Wisconsin (50)
359,499 Results for "f star therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Starton Therapeutics Presents Positive Data from Phase 1b Study Evaluating STAR-LLD for the Treatment of Relapsed/Refractory Multiple Myeloma at the American Association for Cancer Research (AACR) Annual Meeting 2025
April 25, 2025
·
4 min read
Press Releases
Star Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 2, 2025
·
1 min read
Press Releases
Star Therapeutics Receives FDA Fast Track Designation for VGA039 in Von Willebrand Disease (VWD)
January 7, 2025
·
2 min read
Press Releases
Psyence BioMed Signs LOI with Southern Star Research to Expand Phase IIb Clinical Trial in Australia
April 8, 2025
·
7 min read
Press Releases
PESG Report: Silexion Therapeutics’ Systemic Delivery Breakthrough Positions Company as Rising Star in The Multi-Billion Dollar Precision Oncology Market
January 29, 2025
·
3 min read
Biotech Bay
Star Therapeutics Presents Clinical Data for VGA039, a Subcutaneous Therapy for the Treatment of Von Willebrand Disease (VWD)
Star Therapeutics today announced the presentation of clinical data from VIVID 1 (VGA039 Investigation in Von Willebrand Disease), a Phase 1 clinical study of VGA039 in healthy volunteers.
June 26, 2024
·
4 min read
Press Releases
E-Star BioTech Announces Presentation During 2025 Annual Meeting of the American College of Cardiology
March 27, 2025
·
2 min read
Deals
invoX Pharma Completes Acquisition of F-star Therapeutics, Inc.
InvoX Pharma Limited (“invoX”), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited (“Sino Biopharm”) (HKEX 1177 HK) with an advancing pipeline of innovative products, today announces that it has successfully completed the acquisition of F-star Therapeutics, Inc. (“F-star”) (NASDAQ:FSTX).
March 8, 2023
·
6 min read
Business
F-star, an invoX Company, Announces Strategic Collaboration and Licence Agreement with Takeda to Discover and Develop Next-Generation Multi-Specific Antibodies
F-star Therapeutics , an invoX company (“F-star”) , today announced that it has entered into a strategic discovery collaboration and licence agreement with Takeda.
July 5, 2023
·
4 min read
Press Releases
A*STAR And MojiaBio To Develop Next-gen Sustainable Biomanufacturing Platform In Singapore
February 28, 2025
·
7 min read
1 of 35,950
Next
